Table 5 Analysis of within-cat activity data ( n = 35), showing the number and percentage of cats in which hourly activity counts were significantly higher during either placebo (P) or robenacoxib (R) treatment for each method of partitioning the data.

From: Robenacoxib shows efficacy for the treatment of chronic degenerative joint disease-associated pain in cats: a randomized and blinded pilot clinical trial

Group

n (% of total) of cats with activity R > P

n (% of total) of cats with activity P > R

P value

Difference in response rates (R – P)

NNT

Total mean hourly values, entire day

8 (22.9%)

2 (5.71%)

0.058

17.2%

5.83

Non-zero mean hourly values, entire day

10 (28.6%)

2 (5.71%)

0.021*

22.9%

4.37

Dusk-to-dawn mean hourly values

9 (25.7%)

2 (5.71%)

0.035*

20.0%

5.0

Non-zero mean hourly values, dusk-to-dawn

6 (17.1%)

1 (2.86%)

0.059

14.3%

7.0

  1. NNT number needed to treat.
  2. *Significance at 0.05 level, n = number
Back to article page